Literature DB >> 21833528

Susceptibility to ankylosing spondylitis: evidence for the role of ERAP1, TGFb1 and TLR9 gene polymorphisms.

Wenliang Wu1, Yan Ding, Yunzhen Chen, Zhao Hua, Haichun Liu, Hongliang Wang, Guangjun Jiao.   

Abstract

Genetic factors are thought to be crucial in the pathogenesis of ankylosing spondylitis (AS). Recent studies have reported that ERAP1, TGBβ1 and TLRs genes are likely to have association with AS in different populations. We carried out this study to determine whether single-nucleotide polymorphisms covering the three genes are associated with AS in a Chinese Han population. Genomic DNA was isolated from the peripheral blood of 328 patients with AS and 627 healthy blood donors from Jinan region as a case-control study. The diagnosis of AS was made according to the modified New York criteria. The ERAP1 rs27044, TGBβ1 rs1800470 and TLR9 rs55704465 were genotyped by a polymerase chain reaction--restriction fragment length polymorphism method. Strong association with AS was observed for marker rs27044, but no significant differences were observed between AS patients and controls in the frequencies of the carriership of the alleles rs55704465 and rs1800470. Our data thus indicate that ERAP1 likely constitutes one of AS-associated loci of susceptibility after HLA in Chinese Han population. On the contrary, TGFB1 and TLR9 variations show no association with the susceptibility of AS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833528     DOI: 10.1007/s00296-011-1994-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

Review 1.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

3.  Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms.

Authors:  M van der Paardt; J B A Crusius; M A García-González; B A C Dijkmans; A S Peña; I E van der Horst-Bruinsma
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 4.  Genetics and genomics of ankylosing spondylitis.

Authors:  Gethin P Thomas; Matthew A Brown
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

5.  Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis.

Authors:  W P Maksymowych; R D Inman; D D Gladman; J P Reeve; A Pope; P Rahman
Journal:  Arthritis Rheum       Date:  2009-05

6.  The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis.

Authors:  E Jaakkola; A M Crane; K Laiho; I Herzberg; A-M Sims; L Bradbury; A Calin; S Brophy; M Kauppi; K Kaarela; B P Wordsworth; J Tuomilehto; M A Brown
Journal:  Rheumatology (Oxford)       Date:  2003-07-30       Impact factor: 7.580

Review 7.  Genetic susceptibility to ankylosing spondylitis.

Authors:  Anne-Marie Sims; B Paul Wordsworth; Matthew A Brown
Journal:  Curr Mol Med       Date:  2004-02       Impact factor: 2.222

8.  Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding.

Authors:  Xinle Cui; Feras Hawari; Sura Alsaaty; Marion Lawrence; Christian A Combs; Weidong Geng; Farshid N Rouhani; Dianne Miskinis; Stewart J Levine
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 9.  Prevalence of rheumatic diseases and disability in China.

Authors:  Yao-Jun Xiang; Sheng-Ming Dai
Journal:  Rheumatol Int       Date:  2008-12-06       Impact factor: 2.631

10.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  7 in total

Review 1.  Associations between ERAP1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Clin Rheumatol       Date:  2016-04-25       Impact factor: 2.980

2.  Significant association between insertion/deletion polymorphism of the angiotensin-convertig enzyme gene and ankylosing spondylitis.

Authors:  Ahmet Inanır; Serbulent Yigit; Sengul Tural; Sibel Demir Ozturk; Songul Akkanet; Abdulkadir Habiboğlu
Journal:  Mol Vis       Date:  2012-07-26       Impact factor: 2.367

3.  Associations between ERAP1 polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis of East Asian Population.

Authors:  Yuqing Jiang; Yi Ren; Dong Zhou; Youjia Xu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

4.  Lack of Association between Cytokine Genetic Polymorphisms in Takayasu's Arteritis in Mexican Patients.

Authors:  María Elena Soto; Claudia Huesca-Gómez; Yazmín Torres-Paz; Giovanny Fuentevilla-Álvarez; Ricardo Gamboa
Journal:  Int J Environ Res Public Health       Date:  2019-12-03       Impact factor: 3.390

5.  Ankylosing spondylitis: from cells to genes.

Authors:  José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2013-07-21

6.  Bioinformatics analysis of genetic variants of endoplasmic reticulum aminopeptidase 1 in ankylosing spondylitis.

Authors:  Xiaoli Wang; Jie Ma; Jianbing Ma; Yurong Wen; Liesu Meng; Hao Yang; Rui Zhang; Dingjun Hao
Journal:  Mol Med Rep       Date:  2017-08-31       Impact factor: 2.952

7.  Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy.

Authors:  Agata Sebastian; Patryk Wojtala; Łukasz Lubiński; Małgorzata Mimier; Arkadiusz Chlebicki; Piotr Wiland
Journal:  Reumatologia       Date:  2017-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.